Pheochromocytoma: Diagnostic Workup and Perioperative Management
For suspected pheochromocytoma, initiate biochemical testing with plasma free metanephrines or urinary fractionated metanephrines, followed by CT/MRI localization, and begin preoperative alpha-blockade for 10-14 days before surgical resection to prevent life-threatening perioperative cardiovascular complications.
Diagnostic Workup
Biochemical Testing
Measure plasma free metanephrines or urinary fractionated metanephrines as the initial diagnostic test 1. When drawing plasma metanephrines, position the patient supine and use reference intervals established in the same position to minimize false-positives 1. Liquid chromatography with mass spectrometry or electrochemical detection is preferred over other laboratory methods for accuracy 1.
All positive results require appropriate follow-up based on the degree of elevation and clinical presentation 1. The classic triad of headaches, sweating, and palpitations occurs in only 20% of patients, though nearly all patients exhibit at least one of these symptoms 2.
Imaging Localization
Once biochemical diagnosis is confirmed, proceed to CT or MRI for tumor localization 1. MRI is preferred for patients with metastatic disease or when radiation exposure must be limited 1. Consider 123I-metaiodobenzylguanidine (MIBG) scintigraphy for metastatic disease 1.
Genetic Testing
Offer genetic testing to all patients with pheochromocytoma, as 30-40% of cases are hereditary 1, 2. Patients with paraganglioma should be tested for SDHx mutations, and those with metastatic disease for SDHB mutations specifically 1. This influences surgical planning, particularly regarding cortical-sparing adrenalectomy in hereditary cases to prevent lifelong steroid dependence 3.
Perioperative Management
Preoperative Preparation (Critical for Mortality Reduction)
Initiate alpha-adrenergic blockade 10-14 days before surgery 4. This is the guideline-backed standard despite recent debates about necessity in low-risk patients 2. The two primary interventions that have reduced perioperative mortality are alpha-blockade and intravascular volume normalization 5.
Alpha-blocker options and dosing:
- Phenoxybenzamine: 10-20 mg two to three times daily 4
- Prazosin: 1-3 mg two to three times daily 4
- Doxazosin: 2-4 mg two to three times daily 4
- Terazosin: 2-10 mg two times daily 4
Alternative agents include alpha-methyldopa or clonidine 4.
Critical timing rule: Avoid beta-blockers until adequate alpha-blockade is achieved 4. Beta-blockers should only be added if arrhythmias are present after establishing alpha-blockade, to prevent unopposed alpha-stimulation and hypertensive crisis.
Consider adding metyrosine (tyrosine hydroxylase inhibitor): 0.25-1 g four times daily 4. This provides additional catecholamine synthesis inhibition.
Ensure high-sodium diet and adequate fluid intake preoperatively to prevent postoperative hypotension 1. Immediately before surgery, administer intravenous fluids for volume expansion to avoid shock after tumor removal 4.
Surgical Planning
Surgical resection should be carefully planned with a multidisciplinary team including surgical, medical, intensivist, and anesthesia consultants experienced in pheochromocytoma management 4, 6.
Laparoscopic surgery is preferred over open surgery for resection, except for very large tumors 4. Both transabdominal and retroperitoneal approaches are considered equivalent; choice depends on surgeon expertise 2. Partial adrenalectomy is an option for selected patients, particularly those with hereditary syndromes 1.
Intraoperative Management
Have phentolamine hydrochloride readily available and administer intravenously if hypertensive crises occur before or during surgery 4.
Use intravenous propranolol for treatment of arrhythmias 4.
The anesthesiologist must be prepared to manage both hypertension and hypotension, as intraoperative hemodynamic instability correlates with poorer outcomes 5. No specific anesthetic technique has proven superior 5.
Special Circumstance: Previously Undiagnosed Pheochromocytoma During Unrelated Surgery
If pheochromocytoma is suspected intraoperatively during unrelated surgery, prioritize immediate stabilization and cessation of surgery when feasible 6. Communicate closely with the surgical team about whether to abort, limit, or continue based on urgency and patient status. In most cases, nonessential surgery should be aborted 6.
Pregnancy Considerations
Early pregnancy: If termination is chosen, perform under alpha and beta blockade, followed immediately by tumor resection 4, 7.
Late pregnancy: Provide alpha and beta blockade, followed by elective cesarean section and immediate tumor resection 4, 7.
Postoperative Care
Admit patients to intensive care for close monitoring for at least 24-48 hours 8. Monitor and manage postresection hypoglycemia and vasoplegia when they occur 6. The postoperative level of care should be based on intraoperative course and institutional protocols 6.
Lifelong annual follow-up is recommended to detect recurrent or metastatic disease 1, 5. Many patients remain hypertensive following surgical removal and require ongoing antihypertensive management 4.
Management of Inoperable or Metastatic Disease
For patients with inoperable or metastatic malignant pheochromocytoma, control blood pressure and adrenergic symptoms with alpha-adrenergic blockade (phenoxybenzamine, prazosin, doxazosin, terazosin) plus beta-blockade and/or tyrosine hydroxylase inhibition with metyrosine 4. Chemotherapy with cyclophosphamide, vincristine, and dacarbazine may be used 4. High-dose iodine-131 MIBG induces moderate response and may help control blood pressure 4.